Reguverse Knowledge Base

English

中文

English

中文

Appearance

Medical Device Reporting for User Facilities ​

Published: 1996-04-01

Status: Final Type: Guidance Document Category: Postmarket / Recalls / Vigilance Topics: Radiological Health Docket: FDA-2020-D-0957

Official Source

https://www.fda.gov/regulatory-information/search-fda-guidance-documents/medical-device-reporting-user-facilities PDF: https://www.fda.gov/media/73972/download

Official Full Text ​

  1. Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 Table 1 - Summary of MDR Reporting Requirements . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 Table 2 - Summary of Other MDR Requirements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
  2. User Facility Reporting Requirements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3 Type of reports . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3 Individual adverse event reports . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3 Semiannual reports . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3 Individual adverse event report data elements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3 Semiannual report data elements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3 When to report . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4 “Information that reasonably suggests” . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4 “Information that is reasonably known” to user facilities . . . . . . . . . . . . . . . . . . . . . . . . . . . 4 Requests for additional information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4 When not to file . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4 Exemptions, variances, and alternative reporting . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 English reporting requirements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 Reporting codes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 Electronic reporting . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 Where to get forms and coding manual . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 Where to submit reports . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5
  3. Written Procedures, Record Keeping, and Public Disclosure . . . . . . . . . . . . . . . . . . . . . . . . . 7 Written procedures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7 Files . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7 Public availability of reports . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7 Disclaimers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
  4. Enforcement . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9 Authority to Enforce MDR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9 Criminal penalty authority . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9 Civil penalty authority . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9
  5. Definitions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11 Ambulatory surgical facility . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11 “Becomes aware” . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11 “Caused or contributed to” . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11 Device user facility . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11 Hospital . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11 Malfunction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12 MDR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12 MDR reportable event . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12 Medical personnel . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12 Nursing home . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12

viii Outpatient diagnostic facility . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12 Outpatient treatment facility . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13 Patient of the facility . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13 Physician’s office . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13 Serious injury . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13 Permanent . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14 User facility reporting number . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14 Work day . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14 6. Frequently asked questions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15 Appendices

A. FDA Form 3500A (mandatory MedWatch form) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21 ​

B. Form FDA 3419 (MDR Semiannual Report) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23 ​

C. Abbreviated Instructions for FDA Form 3500A Specific to MDR . . . . . . . . . . . . . . . . . 25 ​

  1. INTRODUCTION In 1990, Congress enacted the Safe Medical Devices Act (SMDA) to increase the information that the Food and Drug Administration (FDA) and manufacturers receive about serious problems with medical devices. Although manufacturers and importers of medical devices have been required since 1984 to report to FDA all device-related deaths, serious injuries, and certain malfunctions, numerous reports show widespread under reporting. A 1986 General Accounting Office (GAO) study showed that hospitals reported less than one percent of problems with medical devices and, the more serious the problem with a medical device, the less likely it was to be reported. A GAO follow-up study in 1989 concluded that despite full implementation of the Medical Device Reporting (MDR) regulation, serious under reporting still existed. Under SMDA, device user facilities and manufacturers must report deaths and serious injuries to which a device has or may have caused or contributed and must establish and maintain adverse event files. A device user facility is defined as a hospital, an ambulatory surgical facility, a nursing home, an outpatient treatment facility, or an outpatient diagnostic facility which is not a physician’s office. A medical device is any item that is used for the diagnosis, treatment, or prevention of a disease, injury, or other condition and is not a drug or biologic. (See sections 5 and 6 for definitions of terms and concepts.) The user facility reporting section of SMDA became effective on November 28, 1991. To implement SMDA, FDA published a tentative final rule in the November 26, 1991, Federal Register and invited comments on the regulation. Over 300 comments were received. Then, on June 16, 1992, the President signed into law the Medical Device Amendments of 1992 (Public Law 102-300; the Amendments of 1992), amending certain provisions (section 519 of the Food, Drug, and Cosmetic Act) relating to reporting of adverse events. The primary impact of the 1992 Amend-ments on user facility reporting was to establish a single reporting standard for user facilities, manufacturers, and importers. The final medical device reporting rule published in the December 11, 1995, Federal Register addresses the comments received by FDA and the changes mandated by the Amendments of 1992. For easy reference, sections of the MDR regulation are enclosed in brackets following terms and concepts. The following tables summarize the MDR requirements for user facilities and manufacturers. Table 1 - Summary of MDR Reporting Requirements REPORTER REPORT WHAT? TO WHOM? WHEN? User Facility Deaths FDA and Within 10 work days Manufacturer Serious injuries* Manufacturer Within 10 work days FDA only if manufacturer unknown Semiannual report of deaths FDA January 1 and July 1 and serious injuries Manufacturer 30-day reports of deaths, FDA 30 days from becoming aware serious injuries* and malfunctions Baseline report to identify FDA With 30-day report when and provide basic data on device is reported for first time each device that is subject of a report 5-day report on events that FDA Within 5 work days require immediate remedial action and other types of events designated by FDA Annual certification of FDA When firm submits annual compliance with regulation registration
  • Serious injury definition no longer necessitates “immediate” intervention, just medical or surgical intervention. Table 2 - Summary of Other MDR Requirements REQUIREMENT APPLIES TO SUMMARY Files User facilities and Records of complaints and MDR reports must be kept manufacturers for a period of two years or, for manufacturers, the expected life of the device, if longer. Written MDR User facilities and Written procedures must be developed, maintained and Procedures manufacturers implemented for (1) identification, evaluation, and timely submission of MDR reports, and (2) compliance with record keeping requirements. Exemptions, User facilities and Investigational devices are exempt. Exemptions, Variances and manufacturers variances or alternatives to any or all of the reporting Alternative requirements may be granted upon request or at the Reporting discretion of FDA. Designation of Foreign manufacturers Foreign manufacturers must designate an agent in the U.S. Agent U.S. who will register and submit MDR reports, conduct or obtain information about investigations, forward reports to the manufacturer and maintain complaint files on behalf of the manufacturer.
  1. USER FACILITY REPORTING REQUIREMENTS User facilities must report deaths and serious injuries when they become aware of information that reasonably suggests a medical device has or may have caused or contributed to the adverse event. They must also establish and maintain adverse event files. 2.1 Type of reports 2.2 Individual adverse event report data User facilities are required to file two types of reports: Individual adverse event reports [§803.30] • patient information (block A); Individual adverse event reports include • description of adverse event or product reports of death and serious injury which are problem (block B); submitted on FDA Form 3500A or an electronic equivalent. • suspect medical device information A user facility must report to the device manufacturer and FDA whenever the facility has information that reasonably suggests a device has or may have caused or contributed to a patient’s death. If a facility has information that reasonably suggests a device has or may have caused or contributed to a patient’s serious injury, it must report this information to the device manufacturer. If the manufacturer is not known, the report should be sent to FDA. Semiannual reports [§803.33] If any individual adverse event report was submitted during the previous 6-month reporting period, a user facility must submit a semiannual report to FDA on FDA Form 3419, or an approved electronic equivalent. Semiannual reports are due by January 1 (for reports made July through December) and by July 1 (for reports made January through June) of each year. A semiannual report should not be submitted if no individual reports were submitted to FDA or manufacturers during the reporting period. elements [§803.32] User facility reports (using FDA Form 3500A) must contain the following: (Block D); • initial reporter information (Block E); and • user facility information (Block F) 2.3 Semiannual report data elements [§803.33] A semiannual report must contain the following information: • user facility’s Health Care Facility Administration (HCFA) provider number or number assigned by FDA; • reporting year and period, e.g., January through June or July through December; • facility’s name and complete address; • total number of reports attached or summarized; • date of the semiannual report and the lowest and highest report numbers submitted during the report period; e.g., 1234567890-1995-0001 through 1000; • name, position title, and complete Semiannual reports are due on January 1 address of the individual designated and July 1. as the facility contact person responsible for reporting to FDA, and whether or not that person is a new contact for that facility; and • information for each reportable event that occurred during the semiannual reporting period including:
  • user facility report number;
  • name and address of the device manufacturer;
  • device brand name and common name;
  • product model, catalog, serial, and lot number;
  • a brief description of the event reported to the manufacturer and/or FDA; and
  • where the report was submitted, i.e., to FDA, manufacturer, distributor, etc. In lieu of submitting a summary of each reported event, a user facility may complete only Part 1 of FDA Form 3419 and attach a copy of each mandatory report (FDA Form 3500A, or an approved electronic equivalent) filed during the reporting period. The copies and envelope should be clearly identified as “Semiannual Report.” 2.4 When to report [§803.20] All individual reports of death and serious injury must be submitted within 10 work days from the time that any medical relate the request to a reported event. All personnel of the facility becomes aware of a verbal requests will be confirmed in writing reportable event. by FDA. 2.5 “Information that reasonably suggests” [§803.20(c)] Information that reasonably suggests that a medical device has caused or contributed to a MDR reportable event (i.e., a death or serious injury) includes any information such as professional, scientific, or medical facts and observations or opinions that a device has caused or may have caused or contributed to a reportable event. 2.6 “Information that is reasonably known” to user facilities [§803.30]. User facilities must provide all information that is reasonably known to them. This includes information found in documents in the possession of the user facility and any information that becomes available as a result of reasonable follow-up within the facility. A user facility is not required to evaluate or investigate the event by obtaining or evaluating information that is not reasonably known to it. 2.7 Requests for additional information [§803.15] FDA may determine that protection of the public health requires additional or clarifying information for an MDR report. In these instances and when additional information is beyond the scope of FDA reporting forms, or is not readily accessible, the agency will notify the user facility of the additional information that is required. Any request will state the reason or purpose for which the information is being requested, specify the date that the information is to be submitted, and clearly 2.8 When not to file [§803.22] If a user facility becomes aware of information from multiple sources regarding the same patient and same event, only one MDR report is required. An MDR report is not required if the user facility determines that the information received is erroneous, because a device-related adverse event did not occur. Documentation of such reports 2.13 Where to get forms and coding must also be retained in the facility’s MDR manual [§803.11] files for two (2) years. 2.9 Exemptions, variances, and alternative reporting. [§803.19] Upon written application or at its own discretion, FDA may grant a user facility an exemption, a variance, or an alternative form of reporting and may change the frequency of reporting. When FDA grants an exemption, variance, or alternative form of reporting, it may impose other reporting requirements to ensure the protection of public health. It may also revoke or modify any exemption, variance, or alterative form of reporting, if necessary. 2.10 English reporting requirements [§803.13] All required MDR reports must be in English. 2.11 Reporting codes [§803.21] FDA has developed a coding manual for completing FDA Form 3500A. The manual contains hundreds of codes for adverse events and will be updated as needed. The manual is available from various sources (see 2.13 for specifics). 2.12 Electronic reporting [§803.14] Any MDR report may be submitted electronically with prior written consent from the FDA. Such consent is revocable. Electronic report submissions include alternative reporting media (magnetic tape, disc, FAX, etc.) and computer-to-computer communi-cation. Any electronic report meeting electronic reporting standards, guidelines, or other procedures developed by FDA for MDR, will be deemed to have prior approval for use. FDA forms 3500A and 3419, instructions, and the coding manual necessary to complete 3500A are available through the Internet at: http://www.fda.gov After June 1996, the above documents and other MDR guidance will be available from: National Technical Information Service

Springfield, VA 22161 Telephone number (703) 487-4650. See Preface for a complete listing of documents. 2.14 Where to submit reports. [§803.12] All individual adverse event reports, semiannual reports, and any additional information should be sent to: Food and Drug Administration Center for Devices and Radiological Health Medical Device Reporting P.O. Box 3002 Rockville, MD 20847-3002 Each report and its envelope should be specifically identified, e.g., Semiannual Report or User Facility Report. If a user facility believes that there is a public health emergency, it should contact: FDA Emergency Operations Branch, Office of Regional Operations, HFC-162 Telephone number 1-866-300-4374 or 301-796-8240 The telephone report should be followed by a FAX report to 240-276-3454. 3. WRITTEN PROCEDURES, RECORD KEEPING, AND PUBLIC DISCLOSURE User facilities must develop, implement, and maintain written procedures for reporting adverse medical device events. In addition to reporting device-related deaths and serious injuries, user facilities must establish and maintain MDR files. 3.1 Written procedures [§803.17] 3.2 Files [§803.18] Written procedures include internal User facilities must establish and mainsystems that provide: tain MDR event files. MDR event files are • for timely and effective identificauser facility. They must be prominently tion, communication, and evaluidentified as such and filed to facilitate timely ation of adverse events; access. MDR files must contain: • a standardized review process and • information in the possession of the procedure for determining whether user facility or references to infor-or not an event is reportable; and mation related to the event. This • procedures to assure the timely reporting decisions and decisiontransmission of complete reports. making process; and User facilities must also establish, • copies of all completed MDR forms implement, and maintain written procedures and other information submitted to to assure compliance with documentation and FDA, distributors, and manufacrecord-keeping requirements. This includes: turers. • information that was evaluated to Records related to an adverse event, determine if an event was whether reported or not, must be kept for two reportable; (2) years from the date of the event. A user • all MDR reports and information access, at all reasonable times, to all required submitted to FDA and manufacrecords for copying and verification. turers; • any information that was evaluated for the purpose of preparing the submission of semiannual reports; and • systems that ensure access to information that facilitates timely followup and inspection by FDA. written or electronic files maintained by the includes all documentation of the facility must permit FDA employees to have 3.3 Public availability of reports [§803.9] Certain information from MDR reports, including any FDA record of a telephone report, is available for public disclosure. Before public disclosure of a report, FDA will delete from the report: • any information that constitutes trade secret or confidential commercial or financial information; • any personal, medical, and similar • a communication to a manufacturer information (including the serial of a device which is the subject of a number of implanted devices) report required by a user facility; which would constitute an unwarranted invasion of personal • a disclosure relating to an MDR privacy; and report required by a manufacturer or • any names and other identifying information of a third party • a disclosure to employees of the voluntarily submitting an MDR Department of Health and Human report. This includes physicians, Services and to the Department of healthcare professionals, or other Justice or to duly authorized hospital employees, unless they are committees and subcommittees of designated the MDR contact the U.S. Congress. person. FDA will disclose to a patient requesting a report all information in the report concern-ing that patient. FDA will not disclose the identity of a user facility which makes a report except in connection with: • an action brought to enforce the medical device reporting requirements, including the failure or refusal to furnish material or information; distributor; or 3.4 Disclaimers [§803.16] Submission of a report or information under MDR, as well as any release by FDA of that report or information, does not necessarily reflect that FDA or the submitter admit or conclude that the device, the user facility, or its employees caused or contributed to the reportable event. MedWatch Form 3500A contains a disclaimer statement at the bottom of the front page. 4. ENFORCEMENT FDA has criminal and civil penalty authority to enforce the MDR requirements. 4.1 Authority to enforce MDR Criminal penalty authority: Failure to comply with the MDR requirements is a prohibited act under the Food, Drug and Cosmetic Act (FD&C Act). Commission of a prohibited act may subject user facilities to injunction proceedings under Section 302 and criminal penalties under Section 303 of the FD&C Act. Criminal penalties may be up to a $1,000 fine and one year imprisonment for the first offense if the offense was unintentional, and up to $10,000 and three years imprisonment for subsequent offenses, or for intentional offense. Civil penalty authority: Failure to comply with MDR reporting requirements may result in civil penalties if the failure is a significant or knowing departure from the requirements, or a risk to public health. Civil penalties are fines imposed administratively by FDA for noncompliance with the provisions of SMDA. A person who receives a civil penalty is entitled to a hearing before an Admini-strative Law Judge (ALJ). The ALJ’s decision may be appealed to the Commissioner of FDA, and the Commissioner’s decision may be appealed to a U.S. Court of Appeals. Penalties may not exceed $15,000 per violation or $1,000,000 for all violations adjudicated in a single proceeding. 11 5. DEFINITIONS The MDR regulation contains some general terms that apply to user facilities, importers, and manufacturers, as well as terms specific to user facility reporting. For easy reference, sections of the MDR regulation are included in brackets following the term. The following definitions generally apply to user facilities, but the reader should refer to the MDR rule for complete definitions. 5.1 Ambulatory Surgical Facility [§803.3(b)] “Ambulatory Surgical Facility” (ASF) means a distinct entity that operates for the • malfunction; primary purpose of furnishing same day outpatient surgical services to patients. An ASF • improper or inadequate device may be either an independent entity (i.e., not design; a part of a provider of services or any other facility) or operated by another medical entity • manufacture; (e.g., under the common ownership, licensure, or control of an entity). An ASF is • labeling; or subject to the MDR regulation regardless of whether or not it is licensed by a Federal, • user error State, municipal, or local government, or accredited by a recognized accreditation organization. If an adverse event meets the criteria for reporting, the ASF must report the event regardless of the nature or location of the medical service provided by the ASF. 5.2 “Becomes Aware” [§803.3(c)] 5.11), or outpatient treatment facility (see A user facility "becomes aware" of an 5.14) as defined under [§803.3 (w)]. School MDR reportable event when medical pernurse offices and employee health units are sonnel, who are employed by or formally not user facilities. affiliated with the facility, acquire information that reasonably suggests that a reportable event has occurred. “Medical personnel” is defined in 5.9. 5.3 “Caused or Contributed to” diagnostic, therapeutic (medical, [§803.3(d)] A device may have "caused or contributed to" a patient’s death or serious injury, if the death or serious injury was or may have been attributed to the device or the device may have been a factor in the death or serious injury because of: • device failure; 5.4 Device user facility [§803.3(f)] “Device user facility” or “user facility” means a hospital (see definition 5.5), ambulatory surgical facility (see 5.1), nursing home (see 5.10), outpatient diagnostic facility (see 5.12) which is not a “physician’s office” (see 5.5 Hospital [§803.3(i)] “Hospital” means a distinct entity that operates for the primary purpose of providing occupational, speech, physical, etc.), surgical, and other patient services for specific and general medical conditions. Hospital includes general, chronic disease, rehabilitative, psychiatric, and other specialpurpose facilities. A hospital may be either independent (i.e., not a part of a provider of services or any other facility) or may be • has received a diploma or a degree operated by another medical entity (e.g., in a professional or scientific under the common ownership, licensure, or discipline; control of another entity). A hospital is covered by the MDR receiving medical complaints or regulation regardless of whether or not it is adverse event reports; or licensed by a Federal, State, municipal, or local government or accredited by a • is a supervisor of such persons. recognized accreditation organization. If an adverse event meets the criteria for reporting, the hospital must report that event regardless of the nature or location of the medical service provided by the hospital. 5.6 Malfunction [§803.3(m)] another medical entity (e.g., under the A malfunction is failure of a device to an entity) that operates for the primary meet its performance specifications or to purpose of providing: perform as intended. Performance specifications include all claims made in the • skilled nursing care and related labeling for the device. The intended services for persons who require performance of a device refers to the intended medical or nursing care; use for which the device is labeled or marketed. (See 6.14 for user facilities.) • hospice care to the terminally ill; or 5.7 MDR [§803.3(p)] “MDR” means a medical device report. 5.8 MDR Reportable Event [§803.3(q)] An "MDR reportable event" is an event about which a user facility becomes aware of information that reasonably suggests that a device has or may have caused or contributed to a death or serious injury. 5.9 Medical Personnel [§803.3(r)] “Medical personnel” means an individual who: • is licensed, registered, or certified by a State, territory, or other governing body to administer health care; • is an employee responsible for 5.10 Nursing Home [§803.3(s)] “Nursing home” means an independent entity (i.e., not a part of a provider of services or any other facility) or one operated by common ownership, licensure, or control of • services for the rehabilitation of the injured, disabled, or sick. A nursing home is subject to this regulation regardless of whether or not it is licensed by a Federal, State, municipal, or local government, or whether or not it is accredited by a recognized accreditation organization. If an adverse event meets the criteria for report-ing, the nursing home must report that event regardless of the nature or location of the medical service provided by the nursing home. 5.11 Outpatient Diagnostic Facility [§803.3(t)] “Outpatient diagnostic facility” means a distinct entity that: • operates for the primary purpose ofconducting medical diagnostic physical therapy, and treatment for substance tests on patients; abuse. • does not assume ongoing responsi- An outpatient treatment facility may be bility for patient care; and either independent (i.e., not a part of a • provides its services for use by operated by another medical entity (e.g., other medical personnel. Examples under the common ownership, licensure, or include diagnostic radiography, control of an entity). mammography, ultrasonography, electrocardiography, magnetic An outpatient treatment facility is resonance imaging, computerized axial whether or not it is licensed by a Federal, tomography, and in vitro testing. State, municipal, or local government or An outpatient diagnostic facility may be recognized accreditation organization. If an either independent (i.e., not a part of a adverse event meets the criteria for reporting, provider of services or any other facility) or the outpatient treatment facility must report operated by another medical entity (e.g., that event regardless of the nature or location under the common ownership, licensure, or of the medical service provided by the control of an entity). outpatient treatment facility. An outpatient diagnostic facility is covered by the MDR regulation regardless of whether or not it is licensed by a Federal, State, municipal, or local government or is accredited by a recognized accreditation organization. If an adverse event meets the criteria for report-ing, the outpatient diagnostic facility must report that event regardless of the nature or location of the medical service provided by the outpatient diagnostic facility. 5.12 Outpatient Treatment Facility device used at the facility. [§803.3(u)] “Outpatient Treatment Facility” means a distinct entity that operates for the primary purpose of providing nonsurgical therapeutic (medical, occupational, or physical) care on an outpatient basis or home healthcare. Outpatient treatment facilities include ambulance providers, rescue services, and home healthcare groups. Examples of services provided by outpatient treatment facilities include cardiac defibrillation, chemotherapy, radiotherapy, pain control, dialysis, speech or provider of services or any other facility) or covered by the MDR regulation regardless of whether or not it is accredited by a 5.13 Patient of the Facility [§803.3(v)] “Patient of the facility” means any individual who is being diagnosed or treated and/or receiving medical care at or under the control or authority of the facility. For the purpose of the MDR regulation, the definition encompasses employees of the faculty or individuals affiliated with the facility who, in the course of their duties, suffer a device-related death or serious injury that has or may have been caused or contributed to by a 5.14 Physician’s Office [§803.3(w)] “Physician’s office” means a facility that operates as the office of a physician or other healthcare professionals (e.g., dentist, chiropractor, optometrist, nurse practitioner, school nurse offices, school clinics, employee health clinics, or free-standing care units) for the primary purpose of examination, evaluation, and treatment or referral of patients. A physician’s office may be independent, a group practice, or part of a Health Maintenance Organization. manufacturers and FDA. This number 5.15 Serious Injury [§803.3(aa)] “Serious injury” means an injury or illness that is: • life threatening; • results in permanent impairment of a body function or permanent damage to a body structure; or • necessitates medical or surgical intervention to preclude permanent damage or impairment. 5.16 Permanent [§803.3(aa)(2)] Permanent damage or impairment is irreversible damage or impairment that is not trivial. 5.17 User Facility Reporting Number [803.3(dd)] “User facility reporting number” means the number that uniquely identifies each report submitted by a user facility to consists of three parts: • the user facility’s 10-digit Health Care Financing Administration (HCFA) number. If the HCFA number is less than 10 digits, fill the remaining spaces with zeros; • the four-digit calendar year in which the report is submitted; and • the four-digit sequence number of the reports submitted for the year, starting with 0001. For example, a complete number will appear as follows: 1234567890-1996-0001. If a facility has more than one HFCA number, it must select one number that will be used for all of its MDR reports. 5.18 Work day [§803.3(ee)] “Work day” means Monday through Friday, excluding Federal holidays. 6. FREQUENTLY ASKED QUESTIONS The following are questions that FDA is frequently asked. They provide background information on MDR and attempt to explain some of FDA’s policy decisions. 6.1 Why did Congress require medical device reporting for user facilities? Congress enacted the Safe Medical Devices Act of 1990 (SMDA) based on its review of the 1976 Amendments to the Food, Drug, and Cosmetic (FD&C) Act. Congress believed that significant changes were needed in the statutes, so that FDA could better protect the public health. As a result of Congressional hearings and studies conducted by the General Accounting Office, Congress concluded that FDA received less than adequate information about problems with medical devices. With better information, FDA can take appropriate actions to protect the public from hazardous medical devices. 6.2 How do the Medical Device Amendments of 1992 affect medical device reporting? The Medical Device Amendments of 1992 modified the reporting of adverse device events as follows: Adoption of a single reporting standard reportable adverse event. Section 5(a) of the 1992 Amendments revised the reporting requirements for user facilities to report whenever the facility receives or otherwise becomes aware of information that reasonably suggests that a device “has or may have caused or contributed” to the death, serious illness, or serious injury of a patient of the facility. This statutory language change adopts a single standard for manufacturers, importers, and user facilities to determine when injuries caused by devices must be reported to FDA. Single definition of types of injuries that must be reported Section 5(a) of the 1992 Amendments adopted a single definition for the types of injuries that user facilities, manufacturers, importers, and distributors must report. The definition now requires reporting of an injury or illness that is:

• life-threatening; or

• results in permanent impairment of a body function or permanent damage to a body structure; or • necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure. It deleted the SMDA requirement that an injury must require “immediate medical or surgical intervention” to preclude permanent impairment or damage in order to qualify as a New authority to require reporting of “other significant adverse device experiences” The 1992 Amendments also authorized FDA to issue regulations requiring the reporting of “significant adverse device experiences” other than deaths, serious injuries, or serious illnesses that the agency determines are necessary to be reported. This provision will be implemented in a future regulation. 6.3 What is the relationship between medical device reporting and user facility reporting? User facility reporting is a component or 001), and FDA will assign a number for subset of FDA’s Medical Device Reporting future use. The number assigned will be used (MDR) program. Since 1984, manufacturers in FDA’s record of that report and in any and importers have been required to report correspondence with the user facility. All device-related deaths, serious injuries, and zeros should be used subsequent to the first certain malfunctions. SMDA amended the report, if the user does not receive the FDA’s medical device provisions of the Food, Drug, assigned number before the next report is and Cosmetic Act by requiring user facilities submitted. If a facility has multiple sites, the to notify manufacturers and/or FDA of primary site can report centrally and use one reportable events. reporting number for all sites. A primary site 6.4 What is MedWatch and how does it relate to MDR and user facility reporting? MedWatch is FDA’s postmarket surveillance program for reporting adverse events associated with all medical products (drugs, medical devices, biologics, and special nutritional products) regulated by FDA. Medical Device Reporting (MDR) is part of MedWatch, and user facility reporting is a subset of MDR.

6.5 What is the effective date of the final MDR reporting requirements? The user facility reporting section of SMDA has been in effect since November 28, 1991, even though a final regulation for MDR had not been published. Although the original effective date for the final MDR rule was April 11, 1996, FDA has extended the date to July 31, 1996. This will provide additional time for user facilities and manufacturers to prepare for the new requirements. 6.6 Our facility has more than one HCFA number. Which one should we use? If a facility has more than one HCFA number, it must select one to use for all MDR reports. If a facility has no HCFA number, it should use all zeros in the appropriate space in its initial report (e.g., 0000000000-1995-0must provide FDA the name, address, and HCFA number for each respective site with its first report. 6.7 What is a device? The Food, Drug, and Cosmetic Act defines the term “device” as “an instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent, or other similar or related article, including any component, part, or accessory, which is: • recognized in the official National Formulary, or the United States Pharmacopeia, or any supplement to them; • intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease in man or other animals; or • intended to affect the structure or any function of the body of man or other animals, and which is not a drug, i.e., the product does not achieve its primary intended purposes through chemical action within or on the body of man or other animals and which is not User facilities (see 5.4 for definition) dependent upon being metabolized that are part of an HMO or which belong to for the achievement of its primary an HMO must report. intended purposes.” Examples of medical devices (for which FDA has received MDR reports) are hospital beds, heart valves, ventilators, patient restraints, x-ray machines, defibrillators, and bandages. Generally, if it is used in medical practice and it is not a drug or biologic, it is a device. 6.8 Are ambulances and rescue services required to report device-related adverse events? Yes. Ambulances and rescue services fall within the definition of user facility, because they are outpatient treatment facilities. Be-cause of the critical risks posed by potential malfunctions of devices used by such services, FDA has included them in the definition of a user facility. 6.9 Why are home healthcare agencies the posses-sion of the user facility and any required to report under MDR? information that becomes available as a result FDA included home healthcare agencies in the definition of a user facility because of the critical risks posed by potential malfunctions of devices used in home healthcare. Home healthcare agencies (as well as their device distributors) are likely to be the first to learn of problems with critical home healthcare devices such as apnea monitors, ventilators, infusion pumps, etc. 6.10 Are foreign user facilities required Although these reports are voluntary, FDA to report under MDR? recommends that Form 3500A be used to No. Only those user facilities located outside the United States that are operated by the U.S. Government are required to report under MDR. 6.11 Does an HMO have to report? 6.12 Does a user facility need to designate a contact person? [§803.32(e)(4)] Yes. A facility must designate a contact person with whom FDA can conduct its correspondence relating to MDR. A third party may act as a contact person and submit reports for a user facility. 6.13 Are user facilities required to investigate adverse events? In the final MDR rule, FDA has clarified that a user facility must report only information that is “reasonably known” to it and is not required to investigate adverse events by obtaining or evaluating information that is not reasonably known. Reasonably known information includes information found in documents in of reasonable followup within the facility. Of course, the user facility must still make an initial determination as to whether or not an event should be reported under MDR. 6.14 If a device malfunctions but does not cause a death or serious injury, should a report be filed? User facilities are encouraged, but are not required, to report malfunctions that do not result in a death or serious injury. report to the manufacturer, since this form provides for more detail about the event and the device. Such reports provide important information to the manufacturer and FDA concerning device safety. 6.15 What does “permanent damage” or protected? “permanent impairment” mean in the definition for “serious injury?” “Permanent” means irreversible patient identifiers to the public. A reporter impairment or damage to a body structure or may submit an identifier in lieu of a patient’s function, excluding trivial impairment or name. If FDA requires further patient infordamage. While some cosmetic damage may mation, the request will be on an exception be considered trivial, not all cosmetic damage basis. would be considered trivial. 6.16 Is “temporary damage” from use of be used as evidence in a civil action? a device reportable under MDR? Yes, if the “temporary damage” was admissible into evidence or otherwise used in “life-threatening.” Life-threatening events any civil action involving private parties, that may have been caused by or contributed unless the facility, individual, or physician to a device must be reported, regardless of who made the report knew that the whether or not the damage was “temporary.” information in the report was false. However, temporary damage that is not life threatening is not reportable. 6.17 Is an “incident file” the same as an the hospital, releasable under the “MDR event file?” Freedom of Information Act? Because of comments received to the No. FDA will not disclose the identity proposed definition of “incident files,” FDA of physicians or other employees of the user has changed the definition and renamed it facility, although the identity of the user “MDR event files.” MDR event files include facility and MDR contact may be disclosed MDR reports filed (with FDA or other under certain circumstances described in 3.3. entities) and any documents related to the However, the user facility’s MDR contact adverse event. This includes documents person in Block F of MedWatch Form 3500A relating to deliberations and decision-making is releasable. processes used to determine if an event is an MDR reportable event (even if the facility decides not to submit an MDR.) The final MDR regulation also allows Yes. The language of SMDA, as the user facility to incorporate certain amended by the Medical Device Amendinformation by reference (such as medical records, patient files, and engineering reports) rather than include them in the MDR event file. 6.18 Can a patient’s identity be Yes. A patient’s identity will be protected, because FDA does not release any 6.19 Can MDR reports submitted to FDA SMDA states that reports are not 6.20 Is the identity of a reporter of an MDR event, such as a physician at 6.21 Is “user/operator error” reportable under MDR? ments of 1992, requires reporting of all instances that reasonably suggest a device has or may have caused or contributed to a device-related death, serious injury, or serious illness. FDA needs to be aware of events that are related to user error any time such an that many incidents were the result of error has or may have caused or contributed improper use of the device or inadequate to a reportable event. By receiving monitoring of the restrained patient. In information about user problems, FDA can response to these findings, FDA issued a determine whether or not additional measures safety alerts to warn the public about dangers are necessary to resolve the problem, e.g., associated with the use of patient restraints. relabeling or redesign of the device. In addition, FDA designated restraints as 6.22 Must a user facility allow the manufacturer of a device (involved in a patient’s death or serious injury) access to it? FDA has no legal authority to require that a device be returned to the manufacturer In 1995, FDA received over 100,000 or that a manufacturer have access to the MDR reports, many of which were submitted device. However, FDA believes that the by user facilities. manufacturer of a device should evaluate any problems with its device. FDA encourages users to permit access to or return of the device to the manufacturer for evaluation. 6.23 Does MDR really help prevent device problems? Yes. For example, a review of MDR reports concerning patient restraints revealed 34 deaths and 11 injuries. FDA’s review also found prescrip-tion devices and issued a letter to manufacturers to revise their labeling to prevent such improper use. Without the MDR reports, FDA would not have known that these actions were needed to protect the public health. 21 Appendix A 23 Appendix B 25 Appendix C ABBREVIATED INSTRUCTIONS FOR FDA FORM 3500A SPECIFIC TO MEDICAL DEVICE REPORTING GENERAL INSTRUCTIONS

F. For use by user facility/distributor-devices only ​

  1. Complete all sections and items that apply and type all F2 Use the same report number as used on page 1 (see entries. item 4 of General Instructions).
  2. Use the following codes when information is not available F7 If follow-up report, record the user facility or distributor for any item: NA - not applicable; NI - no information yet but initial report number in block F2 and the sequence maybe later; UNK - unknown. number of this follow-up in the blank after “follow-up”,
  3. Enter dates in following format: MM/DD/YY (e.g., June 3, e.g., for first follow-up enter “1”, for second enter “2.” Do 1995 = 06/03/95. If exact date not known, provide best not repeat previously submitted information on a followestimate. Use YYYY for year 2000 and beyond. up report.
  4. Enter the user facility report number or distributor report F10 Enter up to 3 “patient” and 3 “device” codes that most number and/or manufacturer report number in upper right accurately describe the event. Place only one code in corner of page 1. This has the format NNNNNNNNNN-YYYYeach box. Patient codes describe what happened to the XXXXX where Ns represent the 10-character HCFA number patient as a result of the event and device codes of the user facility or the 7 digit registration or identification describe device failures or problems during the event. number of the manufacturer or distributor; YYYY is the year of

G. All manufacturers ​

the report and XXXXX is the 4 or 5 digit sequence number of G1 Enter the full name and address of the manufacturer the report for the reporting year (see 21 CFR 803 or reporting site (contact office) including contact name. guidelines). The name and address of the manufacturing site, if 5. Attach a continuation page(s) when entries exceed allowed different, must also be included in this block. space and indicate the report section and block number on G3 Check source of reported information. If “literature” is each page. checked, attach a copy of the article (in English) and 6. Use the coding manual to complete blocks F10, H3, & H6. record the literature citation in block H10. Check the Ordering information for the Coding Manual, Document “study” box when reporting an RPS/DPS study or Number 799, is available by FAX at (800) 899-0381 or postapproval study. (301) 827-0111. G5-6 Not for medical device use. 7. If more than one patient was involved in the same event, G7 Check “5-day” if five-day report, “Initial” if first or initial complete section A and blocks B2, B5, B6, B7, D10, and F10 submission, or “follow-up” if follow-up or supplemental for each patient. Enter the corresponding patient identifier in submission. If follow-up report, do not repeat previously each block. submitted information. Place manufacturer report 8. If more than one suspect medical device is involved, number of initial report in block G9 and the follow-up complete section D for each. Complete section F for one sequence number on the blank line in block G7 after device and blocks F9, F10, F13 and F14 for each additional “follow-up”. device. Pair each section D with its corresponding section F G8 Not for medical device use. by marking each as follows: “Device 1", “Device 2", etc.

H. Device manufacturers only SPECIFIC INSTRUCTIONS summary. ​

A. Patient information ​

H5 If the question is not relevant to the device (e.g., an x-ray A1 Use an identifier, do not use patient’s name or SSN. machine), check “no”. A2 Give patient’s age or best estimate and indicate the time H6 Codes must be entered for conclusions even if the unit used (years, months, days). device was not evaluated.

B. Adverse event or product problem ​

H7 Check all that apply. B1 Check box 1 if adverse event and/or box 2 if product H10 Enter any additional information, evaluation, or problem. Adverse event is used when reporting a death clarification. Do not duplicate previous information. or serious injury. Product problem is used for a H11 Provide the following additional, corrected or missing malfunction that could lead to a death or serious injury if information, identifying each data item by the applicable it were to recur. block and item number: B2 Check appropriate event outcome. Check “disability” if (1) any information missing on the user facility or the device may have caused or contributed to a distributor report, including any missing or incomplete event permanent injury or impairment. codes required by block F10, B5 Provide a complete description of event. Do not use the (2) information corrected on the user facility or distributor name of any person or institution. If space is inadequate, report form after verification, including any corrected event use continuation sheet(s) as necessary. codes required by block F10

D. Suspect medical device (3) for each event code provided by the user facility or D ​

The Suspect Medical Device is the device that may have distributor in block F10, a statement of whether the type of caused or contributed to the MDR reportable event or the event represented by the code is addressed in the device device that malfunctioned. It is important that the device labeling, e.g., code # 1738 - labeled, code # 1701 - not be properly identified and that all applicable information in labeled, and this block be completed. (4) an explanation of why any required information was H3 If device was evaluated, be sure to attach an evaluation not provided and the steps taken to obtain such information.

Content licensed under CC BY 4.0

Copyright © 2026 RASAAS